ProPhase Labs (PRPH) Capital Expenditures (2010 - 2024)
ProPhase Labs (PRPH) posted Capital Expenditures of $40,000 for Q4 2024, down 83.3% from $239,000 a year earlier.
Powered by 
Analysis
ProPhase Labs (PRPH) Capital Expenditures (2010 - 2024) Analysis & Trends
For FY2024, ProPhase Labs' Capital Expenditures came in at $906,000, down 56.5% from FY2023.
- Annual Capital Expenditures has declined for three consecutive years, though with a five-year compound annual growth rate of 31.8% (FY2019 to FY2024).
- In prior years, ProPhase Labs' Capital Expenditures was $2.08 million in FY2023 (-46.8%), $3.92 million in FY2022 (-7.4%), $4.23 million in FY2021 (+150.5%) and $1.69 million in FY2020 (+640.8%).
- Quarterly Capital Expenditures has run from a low of -$27,000 in Q4 2021 to a high of $3.93 million in Q1 2021 over five years.
- On a year-over-year basis, Capital Expenditures increased in two of the last six quarters, with an average decline of 22.5%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2021, with growth of 900.0%; the weakest was Q4 2023, with a decline of 85.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -321.00 Mn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -763.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 533.00 Mn |
| 10 | ProPhase Labs | 155,925.56 | -390,074.44 | 226,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | -1,000.00 |
| Mar 31, 2024 | 867,000.00 |
| Dec 31, 2023 | 239,000.00 |
| Sep 30, 2023 | 668,000.00 |
| Jun 30, 2023 | 660,000.00 |
| Mar 31, 2023 | 517,000.00 |
| Dec 31, 2022 | 1.60 Mn |
| Sep 30, 2022 | 554,000.00 |
| Jun 30, 2022 | 674,000.00 |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | -27,000.00 |
| Sep 30, 2021 | 21,000.00 |
| Jun 30, 2021 | 310,000.00 |
| Mar 31, 2021 | 3.93 Mn |
| Dec 31, 2020 | 1.47 Mn |
| Sep 30, 2020 | 75,000.00 |
| Jun 30, 2020 | 31,000.00 |
| Mar 31, 2020 | 116,000.00 |
| Dec 31, 2019 | 43,000.00 |
API Access
ProPhase Labs Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PRPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "PRPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=PRPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();